Special: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin

Masters of Scale with Reid Hoffman

By WaitWhat

Special: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin

Since One Medical’s IPO in January, CEO Amir Rubin has been forced to constantly adapt to the coronavirus pandemic, as healthcare needs, expectations, and behaviors shifted. From telemedicine to Covid-19 testing, One Medical has leaned into existing advantages to scale quickly: standing up respiratory care clinics and testing centers; revamping virtual and in-person visits; vetting labs and data. One Medical is now helping other businesses identify new practices to safely bring employees back to work. If you have a consistent platform and mission, explains Amir, that operating system can be applied to even fast-changing environments.

Special: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin
Special: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin
Masters of Scale with Reid Hoffman